DGX and GH Related Headlines
Go Back- Barclays: Life science insiders sold $187M in stock during first quarter
- Guardant Health partners with Quest for blood-based cancer screening
- Guardant Health and Quest Diagnostics Announce Strategic Collaboration to Broaden Access to Guardant’s Shield™ Blood-based Screening Test in the United States

